Skip to main content
Top
Published in: International Urology and Nephrology 6/2020

01-06-2020 | Erectile Dysfunction | Urology - Original Paper

Penile hemodynamics study in erectile dysfunction men: the influence of smoking obesity on the parameters of penile duplex

Authors: Sherif Salah Azab, Ahmed Salem, Nashaat Nabil Ismail, Yasser El Khiat, Mostafa Ahmed El gebally

Published in: International Urology and Nephrology | Issue 6/2020

Login to get access

Abstract

Introduction

Erectile dysfunction (ED) was established to be linked to the risk factors of coronary artery disease such as metabolic syndrome, hypertension, diabetes, smoking, obesity and dyslipidemia.

Objective

To study the influence of smoking and obesity on penile hemodynamics in patients with erectile dysfunction.

Patients and methods

This prospective study was carried out on 130 patients above 40 years and suffering from ED for more than 6 months. Selected patients were divided into four groups: group 1 (nonsmokers/non-obese) N = 36, group 2 (nonsmokers/obese) N = 30, group 3 (smokers/non-obese) N = 34, group 4 (smokers and obese) N = 30. Other risk factors for ED were excluded except dyslipidemia. All patients were subjected to personal history, sexual history, history of medical disorders or operations, evaluation of erectile function using an abridged IIEF-5. Measuring of BMI, fasting lipid profile, blood sugar, TT, prolactin, and PSA was performed. Penile hemodynamics was evaluated using intracavernosal injection of 1 cc Bimix (papaverin + phentolamine) and penile duplex ultrasound measuring the peak systolic velocity (PSV), end diastolic velocity (EDV), resistive index (RI), and cavernosal artery diameter before and after injection.

Results

The mean ages of group 1, group 2, group 3 and group 4 were 50.92 ± 6.52, 55.20 ± 7.18, 50.88 ± 7.66 and 52.30 ± 7.61, respectively, with no statistically significant (p = 0.341). A statistically significant difference observed between mean value of PSV between group 1 and all other groups on both sides and between group 3 and 4. Also, our results recorded a statistically significant difference between mean value of EDV and RI between group 1 and all other groups on both sides. Concerning the change in the cavernosal artery diameter after ICI, there was a significant difference was seen between the following groups 1 and 4, 3 and 4 on both sides and between groups 1 and 2 at right side only. There was a statistically significant difference between the study groups concerning patient’s response to ICI (p value 0.000). A significant negative correlation between BMI and total testosterone was recorded (p = 0.001). Regarding the mean value of testosterone, a significant difference was observed between the different four groups (p = 0.002). And a statistically significant difference was reported between group 1 and group 2 (p = 0.004) and group 2 and group 3 (p = 0.007).

Conclusion

Both smoking and BMI are strong risk factors for ED and affect response to ICI and penile duplex parameters (PSV, EDV, RI). Smoking and BMI together cause more deterioration of penile duplex parameters and response to ICI. The effect of smoking on EDV and RI was more than BMI. The effect of BMI on PSV, response to ICI and testosterone levels was more than smoking.
Literature
1.
go back to reference Hatzimouratidis K (2010) Epidemiology of male sexual dysfunction. Am J Mens Health 1(2):103–125CrossRef Hatzimouratidis K (2010) Epidemiology of male sexual dysfunction. Am J Mens Health 1(2):103–125CrossRef
2.
go back to reference Rosen RC, Cappelleri JC, Smith MD (1999) Development and evaluation of an abridged, 5-item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction. Int J Impot Res 11:319–326CrossRef Rosen RC, Cappelleri JC, Smith MD (1999) Development and evaluation of an abridged, 5-item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction. Int J Impot Res 11:319–326CrossRef
3.
go back to reference Billups KL, Bank AJ, Padma-Nathan H, Katz S, Williams R (2005) Erectile dysfunction is a marker for cardiovascular disease: results of the minority health institute expert advisory panel. J Sex Med 2:40–50CrossRef Billups KL, Bank AJ, Padma-Nathan H, Katz S, Williams R (2005) Erectile dysfunction is a marker for cardiovascular disease: results of the minority health institute expert advisory panel. J Sex Med 2:40–50CrossRef
4.
go back to reference Mirone V, Imbimbo C, Bortolotti A, Di Cintio E, Colli E, Landoni M et al (2002) smoking as risk factor for erectile dysfunction: results from an Italian epidemiological study. Eur Urol 41:294–297CrossRef Mirone V, Imbimbo C, Bortolotti A, Di Cintio E, Colli E, Landoni M et al (2002) smoking as risk factor for erectile dysfunction: results from an Italian epidemiological study. Eur Urol 41:294–297CrossRef
5.
go back to reference Wannamethee SG, Lowe GD, Shaper AG, Rumley A, Lennon L, Whincup PH (2005) Associations between cigarette smoking, pipe/cigar smoking, and smoking cessation, and haemostatic and inflammatory markers for cardiovascular disease. Eur Heart J 26:1765–1773CrossRef Wannamethee SG, Lowe GD, Shaper AG, Rumley A, Lennon L, Whincup PH (2005) Associations between cigarette smoking, pipe/cigar smoking, and smoking cessation, and haemostatic and inflammatory markers for cardiovascular disease. Eur Heart J 26:1765–1773CrossRef
6.
go back to reference Levey HR, Rais-Babrami S, Gbiraldi E et al (2011) Body mass index predicts peak systolic velocity in cavernosal artery. J Sex Med 8(Suppl 1):4–48 Levey HR, Rais-Babrami S, Gbiraldi E et al (2011) Body mass index predicts peak systolic velocity in cavernosal artery. J Sex Med 8(Suppl 1):4–48
7.
go back to reference Kim SH (2002) Doppler US evaluation of erectile dysfunction. Abdom Imaging 27:578–587CrossRef Kim SH (2002) Doppler US evaluation of erectile dysfunction. Abdom Imaging 27:578–587CrossRef
8.
go back to reference Ioakeimidis N, Vlachopoulos C, Rokkas K (2011) Relationship of asymmetric dimethylarginine with penile Doppler ultrasound parameters in men with vasculogenic erectile dysfunction. Eur Urol 5(9):948–955CrossRef Ioakeimidis N, Vlachopoulos C, Rokkas K (2011) Relationship of asymmetric dimethylarginine with penile Doppler ultrasound parameters in men with vasculogenic erectile dysfunction. Eur Urol 5(9):948–955CrossRef
9.
go back to reference Corona G, Mannucci E, Schulman C, Petrone L, Mansani R, Cilotti A et al (2006) Psychobiologic correlates of the metabolic syndrome and associated sexual dysfunction. Eur Urol 50:595–604CrossRef Corona G, Mannucci E, Schulman C, Petrone L, Mansani R, Cilotti A et al (2006) Psychobiologic correlates of the metabolic syndrome and associated sexual dysfunction. Eur Urol 50:595–604CrossRef
10.
go back to reference Rosen MP, Greenfield AJ, Walker TG, Grant P, Dubrow J, Bettman MA et al (1991) Cigarette smoking: an independent risk factor for atherosclerosis in the hypogastric-cavernous arterial bed of men with arteriogenic impotence. J Urol 145:759–763CrossRef Rosen MP, Greenfield AJ, Walker TG, Grant P, Dubrow J, Bettman MA et al (1991) Cigarette smoking: an independent risk factor for atherosclerosis in the hypogastric-cavernous arterial bed of men with arteriogenic impotence. J Urol 145:759–763CrossRef
11.
go back to reference Wu C, Zhang H, Gao Y, Tan A, Yang X, Lu Z, Zhang Y, Liao M, Wang M, Mo Z (2012) The association of smoking and erectile dysfunction: results from the Fangchenggang Area Male Health and Examination Survey (FAMHES). J Androl 33:59–65CrossRef Wu C, Zhang H, Gao Y, Tan A, Yang X, Lu Z, Zhang Y, Liao M, Wang M, Mo Z (2012) The association of smoking and erectile dysfunction: results from the Fangchenggang Area Male Health and Examination Survey (FAMHES). J Androl 33:59–65CrossRef
12.
go back to reference Godtfredsen NS, Prescott E, Osler M, Vestbo J (2001) Predictors of smoking reduction and cessation in a cohort of Danish moderate and heavy smokers. Prev Med 33:46–52CrossRef Godtfredsen NS, Prescott E, Osler M, Vestbo J (2001) Predictors of smoking reduction and cessation in a cohort of Danish moderate and heavy smokers. Prev Med 33:46–52CrossRef
13.
go back to reference Nguyen NT, Magno CP, Lane KT, Hinojosa MW, Lane JS (2007) Association of hypertension, diabetes dyslipidemia, and metabolic syndrome with obesity: findings from the National Health and Nutrition Examination Survey, 1999 to 2004. J Am Coll Surg 207:928–934CrossRef Nguyen NT, Magno CP, Lane KT, Hinojosa MW, Lane JS (2007) Association of hypertension, diabetes dyslipidemia, and metabolic syndrome with obesity: findings from the National Health and Nutrition Examination Survey, 1999 to 2004. J Am Coll Surg 207:928–934CrossRef
14.
go back to reference Roxo L, Virgolino A, Costa J, Alarcao V (2018) Understanding the relationship between BMI and sexual dysfunction: can DSM-5 shed light into this topic? Rev Int Androl 17:130–137PubMed Roxo L, Virgolino A, Costa J, Alarcao V (2018) Understanding the relationship between BMI and sexual dysfunction: can DSM-5 shed light into this topic? Rev Int Androl 17:130–137PubMed
15.
go back to reference Jackson G (2007) Vascular risk factors and erectile dysfunction: ‘sexing-up’ the importance of lifestyle changes. Int J Clin Pract 61:1421–1422CrossRef Jackson G (2007) Vascular risk factors and erectile dysfunction: ‘sexing-up’ the importance of lifestyle changes. Int J Clin Pract 61:1421–1422CrossRef
16.
go back to reference Aversa A, Sarteschi LM (2007) The role of penile color-duplex ultrasound for the evaluation of erectile dysfunction. J Sex Med 4:1437–1447CrossRef Aversa A, Sarteschi LM (2007) The role of penile color-duplex ultrasound for the evaluation of erectile dysfunction. J Sex Med 4:1437–1447CrossRef
17.
go back to reference Wiesmann F, Petersen SE, Leeson PM, Francis JM, Robson MD, Wang Q et al (2004) Global impairment of brachial, carotid, and aortic vascular function in young smokers: direct quantification by high resolution magnetic resonance imaging. J Am Coll Cardiol 44:2056–2064CrossRef Wiesmann F, Petersen SE, Leeson PM, Francis JM, Robson MD, Wang Q et al (2004) Global impairment of brachial, carotid, and aortic vascular function in young smokers: direct quantification by high resolution magnetic resonance imaging. J Am Coll Cardiol 44:2056–2064CrossRef
18.
go back to reference Rehill N, Beck CR, Yeo KR, Yeo WW (2006) The effect of chronic tobacco smoking on arterial stiffness. Br J Clin Pharmacol 61:767–773CrossRef Rehill N, Beck CR, Yeo KR, Yeo WW (2006) The effect of chronic tobacco smoking on arterial stiffness. Br J Clin Pharmacol 61:767–773CrossRef
19.
go back to reference EL Hanbly S, Abdel-Gaber S, Fathy H, EL-Bayoumi Y, Wald M, Niederberger CS (2004) Erectile dysfunction in smokers: a penile dynamic and vascular study from the Department of Andrology, Mansoura University, Mansoura, Egypt; and the Department of Urology, University of Illinois at Chicago, Chicago, Illinois. J Androl 25(6):991–995CrossRef EL Hanbly S, Abdel-Gaber S, Fathy H, EL-Bayoumi Y, Wald M, Niederberger CS (2004) Erectile dysfunction in smokers: a penile dynamic and vascular study from the Department of Andrology, Mansoura University, Mansoura, Egypt; and the Department of Urology, University of Illinois at Chicago, Chicago, Illinois. J Androl 25(6):991–995CrossRef
20.
go back to reference Glina S, Reichet AC, Leao PP (1988) Impact of cigarette smoking on papaverine-induced erection. J Urol 140:523–524CrossRef Glina S, Reichet AC, Leao PP (1988) Impact of cigarette smoking on papaverine-induced erection. J Urol 140:523–524CrossRef
21.
go back to reference Purvis K, Brekke I, Christiansen E (1996) Determinants of satisfactory rigidity after ICI with PGE1 in men with erectile failure. Int J Impot Res 8:9–16PubMed Purvis K, Brekke I, Christiansen E (1996) Determinants of satisfactory rigidity after ICI with PGE1 in men with erectile failure. Int J Impot Res 8:9–16PubMed
22.
go back to reference McVary KT, Carrier S, Wessells H (2001) Smoking and erectile dysfunction: evidence based analysis. J Urol 166:1624–1632CrossRef McVary KT, Carrier S, Wessells H (2001) Smoking and erectile dysfunction: evidence based analysis. J Urol 166:1624–1632CrossRef
23.
go back to reference Zohdy W, Kamal EE, Ibrahim Y (2007) Androgen deficiency and abnormal penile duplex parameters in obese men with erectile dysfunction. J Sex Med 4:797–808CrossRef Zohdy W, Kamal EE, Ibrahim Y (2007) Androgen deficiency and abnormal penile duplex parameters in obese men with erectile dysfunction. J Sex Med 4:797–808CrossRef
24.
go back to reference Bacon CG, Mittleman MA, Kawachi I, Giovannucci E, Glasser DB, Rimm EB (2006) A prospective study of risk factors for erectile dysfunction. J Urol 176:217–221CrossRef Bacon CG, Mittleman MA, Kawachi I, Giovannucci E, Glasser DB, Rimm EB (2006) A prospective study of risk factors for erectile dysfunction. J Urol 176:217–221CrossRef
25.
go back to reference Derby CA, Mohr BA, Goldstein I, Feldman HA, Johannes CB, McKinlay JB (2000) Modifiable risk factors and erectile dysfunction: can lifestlye changes modify risk? Urology 56:302–306CrossRef Derby CA, Mohr BA, Goldstein I, Feldman HA, Johannes CB, McKinlay JB (2000) Modifiable risk factors and erectile dysfunction: can lifestlye changes modify risk? Urology 56:302–306CrossRef
26.
go back to reference Ahn TY, Park JK, Lee SW, Hong JH, Park NC, Kim JJ et al (2007) Prevalence and risk factors for erectile dysfunction in Korean men: results of an epidemiological study. J Sex Med 4:1269–1276CrossRef Ahn TY, Park JK, Lee SW, Hong JH, Park NC, Kim JJ et al (2007) Prevalence and risk factors for erectile dysfunction in Korean men: results of an epidemiological study. J Sex Med 4:1269–1276CrossRef
27.
go back to reference Mulhall J, Teloken P, Brock G, Kim E (2006) Obesity, dyslipidemias and erectile dysfunction: a report of a subcommittee of the sexual medicine society of North America. J Sex Med 3:778–786CrossRef Mulhall J, Teloken P, Brock G, Kim E (2006) Obesity, dyslipidemias and erectile dysfunction: a report of a subcommittee of the sexual medicine society of North America. J Sex Med 3:778–786CrossRef
28.
go back to reference Feldman HA, Johannes CB, Derby CA, Kleinman KP, Mohr BA, Araujo AB (2000) Erectile dysfunction and coronary risk factors: prospective results from the Massachusetts Male Aging Study. Prev Med 30:328–338CrossRef Feldman HA, Johannes CB, Derby CA, Kleinman KP, Mohr BA, Araujo AB (2000) Erectile dysfunction and coronary risk factors: prospective results from the Massachusetts Male Aging Study. Prev Med 30:328–338CrossRef
29.
go back to reference Corona G, Mannucci E, Petrone L, Balercia G, Paggi F, Fisher AD et al (2007) NCEP-ATPIII-defined metabolic syndrome, type 2 diabetes mellitus, and prevalence of hypogonadism in male patients with sexual dysfunction. J Sex Med 4:1038–1045CrossRef Corona G, Mannucci E, Petrone L, Balercia G, Paggi F, Fisher AD et al (2007) NCEP-ATPIII-defined metabolic syndrome, type 2 diabetes mellitus, and prevalence of hypogonadism in male patients with sexual dysfunction. J Sex Med 4:1038–1045CrossRef
30.
go back to reference Kaplan SA, Meehan AG, Shah A (2006) The age-related decrease in testosterone is significantly exacerbated in obese men with the metabolic syndrome. What are the implications for the relatively high incidence of erectile dysfunction observed in these men? J Urol 176:1524–1527CrossRef Kaplan SA, Meehan AG, Shah A (2006) The age-related decrease in testosterone is significantly exacerbated in obese men with the metabolic syndrome. What are the implications for the relatively high incidence of erectile dysfunction observed in these men? J Urol 176:1524–1527CrossRef
31.
go back to reference Laaksonen DE, Niskanen L, Punnonen K, Tuomainen TP, Valkonen VP, Salonen JK (2005) The metabolic syndrome and smoking in relation to hypogonadism in middle-aged men: a prospective cohort study. J Clin Endocrinol Metab 90:712–719CrossRef Laaksonen DE, Niskanen L, Punnonen K, Tuomainen TP, Valkonen VP, Salonen JK (2005) The metabolic syndrome and smoking in relation to hypogonadism in middle-aged men: a prospective cohort study. J Clin Endocrinol Metab 90:712–719CrossRef
32.
go back to reference Esposito K, Giugliano F, Di Palo C, Giugliano G, Marfella R, D’Andrea F et al (2004) Effect of lifestyle changes on erectile dysfunction in obese men: a randomized controlled trial. JAMA 291:2978–2984CrossRef Esposito K, Giugliano F, Di Palo C, Giugliano G, Marfella R, D’Andrea F et al (2004) Effect of lifestyle changes on erectile dysfunction in obese men: a randomized controlled trial. JAMA 291:2978–2984CrossRef
Metadata
Title
Penile hemodynamics study in erectile dysfunction men: the influence of smoking obesity on the parameters of penile duplex
Authors
Sherif Salah Azab
Ahmed Salem
Nashaat Nabil Ismail
Yasser El Khiat
Mostafa Ahmed El gebally
Publication date
01-06-2020
Publisher
Springer Netherlands
Published in
International Urology and Nephrology / Issue 6/2020
Print ISSN: 0301-1623
Electronic ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-020-02405-1

Other articles of this Issue 6/2020

International Urology and Nephrology 6/2020 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine